Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00250068 · ClinicalTrials.gov registry record · Phase 2
Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
A Phase 2 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT00250068: Completed Phase 2 study, sponsored by University of New Mexico.
NCT00250068 is a Phase 2 study that has completed, run by University of New Mexico. The registered enrollment target is 8 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00250068, a Phase 2 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
To determine the overall response rate to liposomal 9-Nitro-20 (S)-Camptothecin (L9NC) administered by aerosolization in patients with non-small-cell lung cancer (any stage. To determine toxicity profile of L9NC administered by aerosolization for 5 consecutive days per week X 8 weeks, every 10 weeks. To perform a pharmacology study of L9NC in the plasma, and the lungs after aerosolization. A specific protocol will be written for this part.
Interventions
- DRUG Liposomal 9-Nitrocamptothecin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2003-04 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
What the finished NCT00250068 record still lists
NCT00250068 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Liposomal 9-Nitrocamptothecin is the first listed.
NCT00250068 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00250068 about?
NCT00250068 is a clinical study titled "Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)". To determine the overall response rate to liposomal 9-Nitro-20 (S)-Camptothecin (L9NC) administered by aerosolization in patients with non-small-cell lung cancer (any stage. To determine toxicity profile of L9NC administered by aerosolization for 5 consecutive days per week X 8 weeks, every 10 week...
What is the current status of trial NCT00250068?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2003-04. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00250068?
The interventions under investigation include: Liposomal 9-Nitrocamptothecin (DRUG).
Who is sponsoring clinical trial NCT00250068?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00250068's enrollment target sits among peer trials
8 1990th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia